Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
Beyond Air (NASDAQ: XAIR) will report financial results for its quarter ended June 30, 2026, on Thursday, August 13, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Beyond Air (NASDAQ: XAIR) will report financial results for its quarter ended June 30, 2026, on Thursday, August 13, 2026. Management will host a conference call and webcast at 8:00 a.m. ET the same day, with domestic and international dial-in options and a post-call online replay.
Details
News Market Reaction – XAIR
On Aug 4, the day this news came out, XAIR closed 2.37% below the previous close. Our momentum scanner recorded 4 alerts for this stock that day. That session’s volume was 1.5x the stock’s average daily volume.
Data tracked by StockTitan Argus for the Aug 4 session.
Key Figures
- Quarter-end date
- June 30, 2026
- Quarter whose financial results will be reported
- Results date
- August 13, 2026
- Scheduled financial results announcement
- Conference call time
- 8:00 a.m. ET
- Scheduled conference call and webcast
Previous Conferences,earnings date Reports
-
Scheduled fiscal fourth-quarter and full-year 2026 results conference call
-
Scheduled third-quarter 2026 results conference call and webcast
-
Scheduled second-quarter 2026 results release and conference call
-
Scheduled first-quarter 2026 financial results conference call
-
Scheduled fiscal-year 2025 financial results conference call
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nitric oxide medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.
| Conference Call & Webcast | |
| Thursday, August 13th @ 8 a.m. ET | |
| Domestic: | 1-877-407-0784 |
| International: | 1-201-689-8560 |
| Conference ID: | 13762077 |
Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.
About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.
CONTACTS:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.